Ucb Sa Adr Stock Shares Outstanding
UCBJY Stock | USD 58.22 1.22 2.14% |
UCB SA ADR fundamentals help investors to digest information that contributes to UCB SA's financial success or failures. It also enables traders to predict the movement of UCB Pink Sheet. The fundamental analysis module provides a way to measure UCB SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UCB SA pink sheet.
UCB |
UCB Shares Outstanding Analysis
UCB SA's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current UCB SA Shares Outstanding | 379.92 M |
Most of UCB SA's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UCB SA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, UCB SA ADR has 379.92 M of shares currently outstending. This is 110.44% higher than that of the Healthcare sector and 255.55% higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is 33.56% higher than that of the company.
UCB Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UCB SA's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of UCB SA could also be used in its relative valuation, which is a method of valuing UCB SA by comparing valuation metrics of similar companies.UCB SA is currently under evaluation in shares outstanding category among related companies.
UCB Fundamentals
Return On Equity | 0.11 | |||
Return On Asset | 0.0468 | |||
Profit Margin | 0.15 % | |||
Operating Margin | 0.19 % | |||
Current Valuation | 16.62 B | |||
Shares Outstanding | 379.92 M | |||
Price To Earning | 17.55 X | |||
Price To Book | 1.55 X | |||
Price To Sales | 2.54 X | |||
Revenue | 5.78 B | |||
Gross Profit | 4.34 B | |||
EBITDA | 1.6 B | |||
Net Income | 1.06 B | |||
Cash And Equivalents | 515 M | |||
Cash Per Share | 1.36 X | |||
Total Debt | 1.97 B | |||
Debt To Equity | 0.34 % | |||
Current Ratio | 1.12 X | |||
Book Value Per Share | 23.47 X | |||
Cash Flow From Operations | 1.55 B | |||
Earnings Per Share | 2.45 X | |||
Price To Earnings To Growth | 6.31 X | |||
Number Of Employees | 8.6 K | |||
Beta | 0.34 | |||
Market Capitalization | 15.86 B | |||
Total Asset | 14.21 B | |||
Retained Earnings | 3 B | |||
Working Capital | (251 M) | |||
Current Asset | 2.46 B | |||
Current Liabilities | 2.71 B | |||
Z Score | 4.8 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 1.54 % | |||
Net Asset | 14.21 B | |||
Last Dividend Paid | 1.3 |
About UCB SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UCB SA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UCB SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UCB SA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. UCB S operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards UCB SA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, UCB SA's short interest history, or implied volatility extrapolated from UCB SA options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ABBV | AbbVie Inc | |
HBI | Hanesbrands | |
MIDU | Direxion Daily Mid |
Check out UCB SA Piotroski F Score and UCB SA Altman Z Score analysis. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for UCB Pink Sheet analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |